drugset / Trial / NCT06736392
Efficacy of Dexmedetomidine As an Adjuvant to Bupivacaine in Pericapsular Nerve Group Block in Hip Replacement Surgeries
RandomizedParallel-groupOpen-labelSupportive care
Summary
Our aim will be to investigate the efficacy of dexmedetomidine as an adjuvant to bupivacaine in ultrasound guided pericapsular nerve group (PENG) block for postoperative analgesia in hip replacement surgeries. * Our primary outcome of the study: total amount of postoperative morphine consumption in the first 24h postoperative. * Our secondary outcome of the study: postoperative analgesia assessed by pain score (by Visual Analog Scale)
Timeline
- Start
- 2025-03-01
- Primary completion
- 2026-08
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 1.5 ug/kg | — |
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | — |
| Comparator | Bupivacaine | Other / unclassified | 20 ml | — |
Indications
No indication recorded.